E Mara Vollema1, Tadafumi Sugimoto2, Mylène Shen3, Lionel Tastet3, Arnold C T Ng4, Rachid Abou1, Nina Ajmone Marsan1, Bart Mertens5, Raluca Dulgheru2, Patrizio Lancellotti2,6, Marie-Annick Clavel3, Philippe Pibarot3, Philippe Genereux7,8,9,10, Martin B Leon7,8, Victoria Delgado1, Jeroen J Bax1. 1. Heart Lung Center, Leiden University Medical Center, Leiden, the Netherlands. 2. GIGA Cardiovascular Sciences, Department of Cardiology, Heart Valve Clinic, University of Liège Hospital, Centre Hospitalier Universitaire Sart Tilman, Liège, Belgium. 3. Institut Universitaire de Cardiologie et de Pneumologie de Québec, Quebec Heart & Lung Institute, Laval University, Quebec City, Quebec, Canada. 4. Department of Cardiology, Princess Alexandra Hospital, University of Queensland, Brisbane, Australia. 5. Department of Medical Statistics, Leiden University Medical Center, Leiden, the Netherlands. 6. Gruppo Villa Maria Care and Research, Anthea Hospital, Bari, Italy. 7. Cardiovascular Research Foundation, New York, New York. 8. New York-Presbyterian Hospital, Columbia University, Medical Center, New York. 9. Gagnon Cardiovascular Institute, Morristown Medical Center, Morristown, New Jersey. 10. Hôpital du Sacré-Coeur de Montréal, Université de Montréal, Montréal, Quebec, Canada.
Abstract
Importance: The optimal timing to operate in patients with asymptomatic severe aortic stenosis (AS) remains controversial. Left ventricular global longitudinal strain (LV GLS) may help to identify patients who might benefit from undergoing earlier aortic valve replacement. Objective: To investigate the prevalence of impaired LV GLS, the natural course of LV GLS, and its prognostic implications in patients with asymptomatic severe AS with preserved left ventricular ejection fraction (LVEF). Design, Setting, and Participants: This registry-based study included the institutional registries of 3 large tertiary referral centers and 220 patients with asymptomatic severe AS and preserved LVEF (>50%) who were matched for age and sex with 220 controls without structural heart disease. The echocardiograms of patients and controls were performed between 1998 and 2017. Exposures: Both clinical and echocardiographic data were assessed retrospectively. Severe AS was defined by an indexed aortic valve area less than 0.6 cm2/m2. Left ventricular global longitudinal strain was evaluated on transthoracic echocardiography using speckle tracking imaging. Main Outcomes and Measures: The prevalence of impaired LV GLS, the natural course of LV GLS, and the association of impaired LV GLS with symptom onset and the need for aortic valve intervention. Results: Two hundred twenty patients (mean [SD] age, 68 [13] years; 126 men [57%]) were included. Despite comparable LVEF, LV GLS was significantly impaired in patients with asymptomatic severe AS compared with age- and sex-matched controls without AS (mean [SD] LV GLS, -17.9% [2.5%] vs -19.6% [2.1%]; P < .001). After a median follow-up of 12 (interquartile range, 7-23) months, mean (SD) LV GLS significantly deteriorated (-18.0% [2.6%] to -16.3% [2.8%]; P < .001) while LVEF remained unchanged. Patients with impaired LV GLS at baseline (>-18.2%) showed a higher risk for developing symptoms (P = .02) and needing aortic valve intervention (P = .03) at follow-up compared with patients with more preserved LV GLS (≤-18.2%). Conclusions and Relevance: Subclinical myocardial dysfunction that is characterized by impaired LV GLS is often present in patients with asymptomatic severe AS with preserved LVEF. Left ventricular global longitudinal strain further deteriorates over time and impaired LV GLS at baseline is associated with an increased risk for progression to the symptomatic stage and the need for aortic valve intervention.
Importance: The optimal timing to operate in patients with asymptomatic severe aortic stenosis (AS) remains controversial. Left ventricular global longitudinal strain (LV GLS) may help to identify patients who might benefit from undergoing earlier aortic valve replacement. Objective: To investigate the prevalence of impaired LV GLS, the natural course of LV GLS, and its prognostic implications in patients with asymptomatic severe AS with preserved left ventricular ejection fraction (LVEF). Design, Setting, and Participants: This registry-based study included the institutional registries of 3 large tertiary referral centers and 220 patients with asymptomatic severe AS and preserved LVEF (>50%) who were matched for age and sex with 220 controls without structural heart disease. The echocardiograms of patients and controls were performed between 1998 and 2017. Exposures: Both clinical and echocardiographic data were assessed retrospectively. Severe AS was defined by an indexed aortic valve area less than 0.6 cm2/m2. Left ventricular global longitudinal strain was evaluated on transthoracic echocardiography using speckle tracking imaging. Main Outcomes and Measures: The prevalence of impaired LV GLS, the natural course of LV GLS, and the association of impaired LV GLS with symptom onset and the need for aortic valve intervention. Results: Two hundred twenty patients (mean [SD] age, 68 [13] years; 126 men [57%]) were included. Despite comparable LVEF, LV GLS was significantly impaired in patients with asymptomatic severe AS compared with age- and sex-matched controls without AS (mean [SD] LV GLS, -17.9% [2.5%] vs -19.6% [2.1%]; P < .001). After a median follow-up of 12 (interquartile range, 7-23) months, mean (SD) LV GLS significantly deteriorated (-18.0% [2.6%] to -16.3% [2.8%]; P < .001) while LVEF remained unchanged. Patients with impaired LV GLS at baseline (>-18.2%) showed a higher risk for developing symptoms (P = .02) and needing aortic valve intervention (P = .03) at follow-up compared with patients with more preserved LV GLS (≤-18.2%). Conclusions and Relevance: Subclinical myocardial dysfunction that is characterized by impaired LV GLS is often present in patients with asymptomatic severe AS with preserved LVEF. Left ventricular global longitudinal strain further deteriorates over time and impaired LV GLS at baseline is associated with an increased risk for progression to the symptomatic stage and the need for aortic valve intervention.
Authors: Victoria Delgado; Laurens F Tops; Rutger J van Bommel; Frank van der Kley; Nina Ajmone Marsan; Robert J Klautz; Michel I M Versteegh; Eduard R Holman; Martin J Schalij; Jeroen J Bax Journal: Eur Heart J Date: 2009-12 Impact factor: 29.983
Authors: Arnold C T Ng; Edgard A Prihadi; M Louisa Antoni; Matteo Bertini; See Hooi Ewe; Nina Ajmone Marsan; Dominic Y Leung; Victoria Delgado; Jeroen J Bax Journal: Eur Heart J Cardiovasc Imaging Date: 2018-08-01 Impact factor: 6.875
Authors: Björn Redfors; Philippe Pibarot; Linda D Gillam; Daniel Burkhoff; Jeroen J Bax; Brian R Lindman; Robert O Bonow; Patrick T O'Gara; Martin B Leon; Philippe Généreux Journal: Circulation Date: 2017-05-16 Impact factor: 29.690
Authors: Patricia A Pellikka; Maurice E Sarano; Rick A Nishimura; Joseph F Malouf; Kent R Bailey; Christopher G Scott; Marion E Barnes; A Jamil Tajik Journal: Circulation Date: 2005-06-13 Impact factor: 29.690
Authors: Helmut Baumgartner; Judy Hung; Javier Bermejo; John B Chambers; Thor Edvardsen; Steven Goldstein; Patrizio Lancellotti; Melissa LeFevre; Fletcher Miller; Catherine M Otto Journal: Eur Heart J Cardiovasc Imaging Date: 2017-03-01 Impact factor: 6.875
Authors: Konstantinos E Farsalinos; Ana M Daraban; Serkan Ünlü; James D Thomas; Luigi P Badano; Jens-Uwe Voigt Journal: J Am Soc Echocardiogr Date: 2015-07-23 Impact factor: 5.251
Authors: Philippe Généreux; Gregg W Stone; Patrick T O'Gara; Guillaume Marquis-Gravel; Björn Redfors; Gennaro Giustino; Philippe Pibarot; Jeroen J Bax; Robert O Bonow; Martin B Leon Journal: J Am Coll Cardiol Date: 2016-04-02 Impact factor: 24.094
Authors: Aamir H Twing; Brody Slostad; Christina Anderson; Sreenivas Konda; Elliott M Groves; Mayank M Kansal Journal: Am J Cardiovasc Dis Date: 2021-04-15
Authors: Gilberto J Aquino; Josua A Decker; U Joseph Schoepf; Landin Carson; Namrata Paladugu; Basel Yacoub; Verena Brandt; Anna Lena Emrich; Florian Schwarz; Jeremy R Burt; Richard Bayer; Akos Varga-Szemes; Tilman Emrich Journal: Radiol Cardiothorac Imaging Date: 2022-06-30